Kaiser Permanente Northern California sepsis mortality reduction initiative

被引:0
|
作者
B Crawford
M Skeath
A Whippy
机构
[1] Kaiser Permanente,
来源
Critical Care | / 16卷 / Suppl 3期
关键词
Septic Shock Patient; Improvement Opportunity; Sepsis Mortality; Bundle Performance; Sepsis Care;
D O I
10.1186/cc11699
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] An integrated EHR at Northern California Kaiser Permanente Pitfalls, challenges, and benefits experienced in transitioning
    Bornstein, S.
    APPLIED CLINICAL INFORMATICS, 2012, 3 (03): : 318 - 325
  • [22] Glyburide versus insulin for the treatment of women with gestational diabetes in Kaiser Permanente Northern California
    Hedderson, Monique M.
    Xu, Fei
    Neugebauer, Romain
    Ferrara, Assiamira
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 230 - 230
  • [23] Dermatologists in Kaiser Permanente-Northern California - Satisfaction, perceived constraints, and policy options
    Weinberg, DJ
    Engasser, PG
    ARCHIVES OF DERMATOLOGY, 1996, 132 (09) : 1057 - 1063
  • [24] Surgical Site Infection Bundle: A Kaiser Permanente Initiative
    Mananquil, Ronda F.
    Ahn, Jungon
    Leong, Stephanie
    AORN JOURNAL, 2019, 110 (03) : 308 - 308
  • [25] Excess maternal transmission of type 2 diabetes - The northern California Kaiser Permanente diabetes registry
    Karter, AJ
    Rowell, SE
    Ackerson, LM
    Mitchell, BD
    Ferrara, A
    Selby, JV
    Newman, B
    DIABETES CARE, 1999, 22 (06) : 938 - 943
  • [26] Use and outcomes of metformin therapy in a large HMO: The Northern California Kaiser Permanente Diabetes Registry
    Selby, J
    Ettinger, B
    Swain, B
    DIABETES, 1998, 47 : A10 - A10
  • [27] Future Hypertension Risk Among a Peripartum Cardiomyopathy Cohort From Kaiser Permanente Northern California
    Fairman, Alix P.
    Choo, Monica
    Xu, Richie Houhong
    Joshi, Nikhil
    Gunderson, Erica P.
    Pursnani, Seema
    CIRCULATION, 2023, 148
  • [28] Human Papillomavirus (HPV) Genotypes in Women with Cervical Precancer and Cancer at Kaiser Permanente Northern California
    Castle, Philip E.
    Shaber, Ruth
    LaMere, Brandon J.
    Kinney, Walter
    Fetterma, Barbara
    Poitras, Nancy
    Lorey, Thomas
    Schiffman, Mark
    Dunne, Anne
    Ostolaza, Janae M.
    McKinney, Sharod
    Burk, Robert D.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (05) : 946 - 953
  • [29] Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004–2007
    Allison W. Kurian
    Daphne Y. Lichtensztajn
    Theresa H. M. Keegan
    Rita W. Leung
    Sarah J. Shema
    Dawn L. Hershman
    Lawrence H. Kushi
    Laurel A. Habel
    Tatjana Kolevska
    Bette J. Caan
    Scarlett L. Gomez
    Breast Cancer Research and Treatment, 2013, 137 : 247 - 260
  • [30] The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California
    Kwan, Marilyn L.
    Ambrosone, Christine B.
    Lee, Marion M.
    Barlow, Janice
    Krathwohl, Sarah E.
    Ergas, Isaac Joshua
    Ashley, Christine H.
    Bittner, Julie R.
    Darbinian, Jeanne
    Stronach, Keren
    Caan, Bette J.
    Davis, Warren
    Kutner, Susan E.
    Quesenberry, Charles P.
    Somkin, Carol P.
    Sternfeld, Barbara
    Wiencke, John K.
    Zheng, Shichun
    Kushi, Lawrence H.
    CANCER CAUSES & CONTROL, 2008, 19 (10) : 1065 - 1076